Related Experiment Video
Updated: Jun 7, 2025
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Evaluation of Lipid Profile Management in Coronary Artery Disease Patients on Statin Therapy: A Single-Centre,
C Sridevi1, Susheel Malani1, Prakash H Chaudhary1
1Cardiology, Dr. D. Y. Patil Medical College, Hospital, and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, IND.
Insights
Many patients with coronary artery disease (CAD) on statin therapy do not reach target low-density lipoprotein cholesterol (LDL-C) levels. This highlights a need for improved lipid management strategies to reduce cardiovascular risk.
Area of Science:
- Cardiology
- Lipid Metabolism
- Pharmacotherapy
Background:
- Lipid control is essential for managing coronary artery disease (CAD) and reducing cardiovascular risk.
- Statins are a cornerstone of lipid-lowering therapy in CAD patients.
Purpose of the Study:
- To evaluate the effectiveness of lipid-lowering therapy, specifically statins, in achieving target lipid levels in patients with CAD.
- To assess the proportion of CAD patients achieving recommended low-density lipoprotein cholesterol (LDL-C) targets.
Main Methods:
- Retrospective, observational study of 72 adult patients with CAD.
- Data collection included lipid profiles and LDL-C levels.
- Primary outcome: proportion of patients achieving 2019 ESC/EAS guideline LDL-C targets.
Main Results:
- A significant proportion of patients did not achieve target LDL-C levels despite statin therapy.
- Suboptimal lipid control was observed in a substantial number of patients.
- Analysis identified areas where current treatment strategies may be insufficient.
Conclusions:
- Many CAD patients on statin therapy exhibit suboptimal lipid control, particularly for LDL-C.
- There is a critical need for more aggressive or tailored lipid-lowering strategies.
- Further research is required to identify factors contributing to poor lipid control and enhance therapeutic effectiveness.
Background:
Lipid control is crucial in managing coronary artery disease (CAD) to reduce cardiovascular risk. This study aimed to evaluate the effectiveness of lipid-lowering therapy, particularly statins, in achieving target lipid levels in patients with CAD.
Materials And Methods:
This single-center, retrospective, observational study was conducted at the Cardiology Outpatient Department of Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pune, Maharastra, India. A sample size of 72 patients was included in this study. Adult patients receiving treatment for acute coronary syndrome (ACS), chronic stable angina (CSA), or unstable angina (UA) were included. Exclusion criteria were comorbidities affecting clinical decisions, HIV-positive status, pregnancy, or breastfeeding. Data on lipid profiles, including low-density lipoprotein (LDL) cholesterol (LDL-C), were collected, with LDL-C calculated using the Friedewald equation or measured directly. The primary outcome was the proportion of patients achieving LDL-C targets as per the 2019 European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guidelines. Statistical analysis was performed using chi-square tests, with significance set at p < 0.05.
Results:
Of the enrolled patients, a substantial proportion did not achieve target LDL-C levels, with LDL-C remaining above the recommended thresholds in a significant number of patients. Despite ongoing statin therapy, lipid control was suboptimal in many cases, particularly among those with elevated LDL-C levels. A detailed analysis of lipid profiles and the achievement of target levels was done, highlighting areas where current treatment strategies may fall short.
Conclusion:
The study reveals that a significant number of patients with CAD on statin therapy do not achieve optimal lipid control, particularly in LDL-C management. This underscores the need for more aggressive or tailored lipid-lowering strategies to reduce residual cardiovascular risk in this high-risk population. Further studies are needed to explore the factors contributing to suboptimal lipid control and to develop interventions that can enhance the effectiveness of current therapies.
More Related Videos
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:22Myocarditis IV: Nursing Management
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:29Cholesterol: Significance and Regulation
Considering cholesterol and...
01:18Lipids: Dietary Sources and Requirements